21 CFR 820.30 Design Controls: Build an FDA-Ready QMS
11 min read
Medical device recalls rarely start on the production line. Most trace back to a decision made months earlier, at the design bench, when a requirement went untested or a review got skipped under deadline pressure. 21 CFR 820.30 design controls exist to catch that kind of gap before a device ever reaches a patient, and […]
Continue reading